News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘OvarianCancer’ clear

  • A new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, a co-author of the commentary on the study, says the test is an important step in that direction.

Tags: CervicalCancer, OvarianCancer, Prevention, GynecologicCancers

  • Research led by Dana-Farber Cancer Institute scientists may soon enable doctors to determine which patients with the most common form of ovarian cancer – high-grade serous ovarian cancer (HGSOC) – are most likely to benefit from a certain class of drugs.

Tags: OvarianCancer, GynecologicCancers

  • Dana-Farber/Brigham and Women's Cancer Center and the Massachusetts Ovarian Cancer Awareness Coalition want women to get the facts and recognize the signs of the disease.

Tags: OvarianCancer, GynecologicCancers

  • Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

Tags: BasicResearch, BreastCancer, Genomics, OvarianCancer, GynecologicCancers

  • The discovery of a subtype of ovarian cancer that could account for up to one-third of all serous ovarian cancers may lead to clinical trials using anti-angiogenic drugs that are already being tested in other cancers.

Tags: OvarianCancer, GynecologicCancers

  • As part of Project Achilles, aimed at finding the "Achilles heel" of cancer, researchers from Dana-Farber Cancer Institute, Harvard and the Broad Institute of MIT examined cells from over 100 tumors, including 25 ovarian cancer tumors, finding promising new targets for genetic research.

Tags: BasicResearch, OvarianCancer, GynecologicCancers

  • Dana-Farber researchers have demonstrated a molecular strategy that they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.

Tags: BreastCancer, OvarianCancer, GynecologicCancers

  • A new Dana-Farber Cancer Institute study suggests there is a direct connection between high-grade serous ovarian cancer (HGSOC) and fallopian tubes. The finding could aid in the development of better treatments for the cancer.

Tags: OvarianCancer, GynecologicCancers

  • A "watch and wait" strategy reduces the need for unnecessary chemo in young girls, which can lead to secondary cancers and other health issues later in life.

Tags: ChildhoodCancer, OvarianCancer, PatientEducation

  • Dana-Farber/Brigham and Women's Cancer Center has joined forces with the Massachusetts Chapter of the National Ovarian Cancer Coalition and The M. Patricia Cronin Foundation to launch a month-long campaign to promote ovarian cancer awareness.

Tags: OvarianCancer

Showing 11-20 of 23 items